Dataset Information

A 2-year pandemic period analysis of facility and county-level characteristics of nursing home coronavirus deaths in the United States, January 1, 2020-December 18, 2021.

ABSTRACT: Nursing home residents are highly susceptible to COVID-19 infection and complications. We used a generalized linear mixed Poisson model and spatial statistics to examine the determinants of COVID-19 deaths in 13,350 nursing homes in the first 2-year pandemic period using the Centers for Medicare and Medicaid Services and county-level related data. The average prevalence of COVID-19 mortality among residents was 9.02 (Interquartile range = 10.18) per 100 nursing home beds in the first 2-year of the pandemic. Fully-adjusted mixed model shows that nursing homes COVID-19 deaths reduced by 5% (Q2 versus Q1: IRR = 0.949, 95% CI 0.901- 0.999), 14.4% (Q3 versus Q1: IRR = 0.815, 95% CI 0.718 - 0.926), and 25% (Q2 versus Q1: IRR = 0.751, 95% CI 0.701- 0.805) of facility ratings. Spatial analysis showed a significant hotspot of nursing home COVID-19 deaths in the Northeast US. This study contributes to nursing home quality assessment for improving residents' health.

SUBMITTER: Iyanda AE

PROVIDER: S-EPMC8858698 | biostudies-literature | 2022 Mar-Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A 2-year pandemic period analysis of facility and county-level characteristics of nursing home coronavirus deaths in the United States, January 1, 2020-December 18, 2021.

Iyanda Ayodeji Emmanuel AE Boakye Kwadwo Adu KA

Geriatric nursing (New York, N.Y.) 20220221

Nursing home residents are highly susceptible to COVID-19 infection and complications. We used a generalized linear mixed Poisson model and spatial statistics to examine the determinants of COVID-19 deaths in 13,350 nursing homes in the first 2-year pandemic period using the Centers for Medicare and Medicaid Services and county-level related data. The average prevalence of COVID-19 mortality among residents was 9.02 (Interquartile range = 10.18) per 100 nursing home beds in the first 2-year of t ...[more]

PMID: 35248837

Similar Datasets

Project description:BackgroundIn Belgium, the first COVID-19 death was reported on 10 March 2020. Nursing home (NH) residents are particularly vulnerable for COVID-19, making it essential to follow-up the spread of COVID-19 in this setting. This manuscript describes the methodology of surveillance and epidemiology of COVID-19 cases, hospitalizations and deaths in Belgian NHs.MethodsA COVID-19 surveillance in all Belgian NHs (n = 1542) was set up by the regional health authorities and Sciensano. Aggregated data on possible/confirmed COVID-19 cases and hospitalizations and case-based data on deaths were reported by NHs at least once a week. The study period covered April-December 2020. Weekly incidence/prevalence data were calculated per 1000 residents or staff members.ResultsThis surveillance has been launched within 14 days after the first COVID-19 death in Belgium. Automatic data cleaning was installed using different validation rules. More than 99% of NHs participated at least once, with a median weekly participation rate of 95%. The cumulative incidence of possible/confirmed COVID-19 cases among residents was 206/1000 in the first wave and 367/1000 in the second wave. Most NHs (82%) reported cases in both waves and 74% registered ≥10 possible/confirmed cases among residents at one point in time. In 51% of NHs, at least 10% of staff was absent due to COVID-19 at one point. Between 11 March 2020 and 3 January 2021, 11,329 COVID-19 deaths among NH residents were reported, comprising 57% of all COVID-19 deaths in Belgium in that period.ConclusionsThis surveillance was crucial in mapping COVID-19 in this vulnerable setting and guiding public health interventions, despite limitations of aggregated data and necessary changes in protocol over time. Belgian NHs were severely hit by COVID-19 with many fatal cases. The measure of not allowing visitors, implemented in the beginning of the pandemic, could not avoid the spread of SARS-CoV-2 in the NHs during the first wave. The virus was probably often introduced by staff. Once the virus was introduced, it was difficult to prevent healthcare-associated outbreaks. Although, in contrast to the first wave, personal protective equipment was available in the second wave, again a high number of cases were reported.

Project description:ImportanceThe number of SARS-CoV-2 infections and COVID-19-associated hospitalizations and deaths prevented among vaccinated persons, independent of the effect of reduced transmission, is a key measure of vaccine impact.ObjectiveTo estimate the number of SARS-CoV-2 infections and COVID-19-associated hospitalizations and deaths prevented among vaccinated adults in the US.Design, setting, and participantsIn this modeling study, a multiplier model was used to extrapolate the number of SARS-CoV-2 infections and COVID-19-associated deaths from data on the number of COVID-19-associated hospitalizations stratified by state, month, and age group (18-49, 50-64, and ≥65 years) in the US from December 1, 2020, to September 30, 2021. These estimates were combined with data on vaccine coverage and effectiveness to estimate the risks of infections, hospitalizations, and deaths. Risks were applied to the US population 18 years or older to estimate the expected burden in that population without vaccination. The estimated burden in the US population 18 years or older given observed levels of vaccination was subtracted from the expected burden in the US population 18 years or older without vaccination (ie, counterfactual) to estimate the impact of vaccination among vaccinated persons.ExposuresCompletion of the COVID-19 vaccination course, defined as 2 doses of messenger RNA (BNT162b2 or mRNA-1273) vaccines or 1 dose of JNJ-78436735 vaccine.Main outcomes and measuresMonthly numbers and percentages of SARS-CoV-2 infections and COVID-19-associated hospitalizations and deaths prevented were estimated among those who have been vaccinated in the US.ResultsCOVID-19 vaccination was estimated to prevent approximately 27 million (95% uncertainty interval [UI], 22 million to 34 million) infections, 1.6 million (95% UI, 1.4 million to 1.8 million) hospitalizations, and 235 000 (95% UI, 175 000-305 000) deaths in the US from December 1, 2020, to September 30, 2021, among vaccinated adults 18 years or older. From September 1 to September 30, 2021, vaccination was estimated to prevent 52% (95% UI, 45%-62%) of expected infections, 56% (95% UI, 52%-62%) of expected hospitalizations, and 58% (95% UI, 53%-63%) of expected deaths in adults 18 years or older.Conclusions and relevanceThese findings indicate that the US COVID-19 vaccination program prevented a substantial burden of morbidity and mortality through direct protection of vaccinated individuals.

Project description:BackgroundCoronavirus Disease 2019 (COVID-19) deaths are rare in children and young people (CYP). The high rates of asymptomatic and mild infections complicate assessment of cause of death in CYP. We assessed the cause of death in all CYP with a positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) test since the start of the pandemic in England.Methods and findingsCYP aged <20 years who died within 100 days of laboratory-confirmed SARS-CoV-2 infection between 01 March 2020 and 31 December 2021 in England were followed up in detail, using national databases, surveillance questionnaires, post-mortem reports, and clinician interviews. There were 185 deaths during the 22-month follow-up and 81 (43.8%) were due to COVID-19. Compared to non-COVID-19 deaths in CYP with a positive SARS-CoV-2 test, death due to COVID-19 was independently associated with older age (aOR 1.06 95% confidence interval (CI) 1.01 to 1.11, p = 0.02) and underlying comorbidities (aOR 2.52 95% CI 1.27 to 5.01, p = 0.008), after adjusting for age, sex, ethnicity group, and underlying conditions, with a shorter interval between SARS-CoV-2 testing and death. Half the COVID-19 deaths (41/81, 50.6%) occurred within 7 days of confirmation of SARS-CoV-2 infection and 91% (74/81) within 30 days. Of the COVID-19 deaths, 61 (75.3%) had an underlying condition, especially severe neurodisability (n = 27) and immunocompromising conditions (n = 12). Over the 22-month surveillance period, SARS-CoV-2 was responsible for 1.2% (81/6,790) of all deaths in CYP aged <20 years, with an infection fatality rate of 0.70/100,000 SARS-CoV-2 infections in this age group estimated through real-time, nowcasting modelling, and a mortality rate of 0.61/100,000. Limitations include possible under-ascertainment of deaths in CYP who were not tested for SARS-CoV-2 and lack of direct access to clinical data for hospitalised CYP.ConclusionsCOVID-19 deaths remain extremely rare in CYP, with most fatalities occurring within 30 days of infection and in children with specific underlying conditions.

Dataset Information

A 2-year pandemic period analysis of facility and county-level characteristics of nursing home coronavirus deaths in the United States, January 1, 2020-December 18, 2021.

Publications

A 2-year pandemic period analysis of facility and county-level characteristics of nursing home coronavirus deaths in the United States, January 1, 2020-December 18, 2021.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets